9 November 2023
ECO Animal Health Group plc
Capital Markets Day Events - R&D Portfolio
ECO Animal Health Group plc (AIM: EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that it will be hosting two Capital Markets events focused on progress and developments in the Company's Research & Development portfolio today, Thursday 9 November 2023.
No new material information will be disclosed at the events.
For further information please contact:
| ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)
| 020 8447 8899 |
| IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630 |
| Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher
| 020 7496 3000 |
| Investec (Joint Broker) Gary Clarence Lydia Zychowska Carlo Spingardi
| 020 7597 5970
|
| Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.